Regeneron Pharmaceuticals competitorsClear all

Regeneron Pharmaceuticals's top competitors include Idorsia, Celgene, Amgen, Sanofi, Biogen, Alexion Pharmaceuticals and Catalent.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines for the treatment of eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Celgene
Celgene
Celgene Corporation is a biopharmaceutical company.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Sanofi
Sanofi
Sanofi provides therapeutic solutions.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Alexion Pharmaceuticals
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Catalent
Catalent
Catalent (also known as Catalent Pharma Solutions) is a company providing integrated services, drug delivery technologies, and manufacturing solutions.
Founding Date
Founding Date
1988
Founding Date
2017
Founding Date
1986
Founding Date
1980
Founding Date
2004
Founding Date
1978
Founding Date
1992
Founding Date
2007
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Greater London, GB
Bernards, US
Rensselaer, US
Washington, US
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Locations
Summit, US HQ
Singapore, SG
Boudry, CH
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Diegem, BE
see more
Locations
Paris, FR HQ
Macquarie Park, AU
Ontario, CA
Beijing, CN
Hong Kong, HK
New Delhi, IN
Tokyo, JP
see more
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
São Paulo, BR
Toronto, CA
Prague, CZ
see more
Locations
Franklin Township, US HQ
Loma Hermosa, AR
Braeside, AU
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
see more
Employees
Employees
8,1009% increase
Employees
8007% increase
Employees
N/A
Employees
23,4009% increase
Employees
104,2262% decrease
Employees
7,4005% decrease
Employees
2,6565% increase
Employees
12,30015% increase
Valuation ($)
Valuation ($)
61.3 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
132.7 b
Valuation ($)
126.1 b
Valuation ($)
50.1 b
Valuation ($)
25.4 b
Valuation ($)
11.6 b
Twitter followers
Twitter followers
21.3 k
Twitter followers
852
Twitter followers
26.8 k
Twitter followers
89.4 k
Twitter followers
128.8 k
Twitter followers
32 k
Twitter followers
5 k
Twitter followers
18.4 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
36
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
72
Number of tweets (last 30 days)
50
Number of tweets (last 30 days)
72
Number of tweets (last 30 days)
26
Number of tweets (last 30 days)
94
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
16.6
Average likes per tweet (last 30 days)
18
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
21.3
Average likes per tweet (last 30 days)
31
Average likes per tweet (last 30 days)
34.4
Average likes per tweet (last 30 days)
7.6
Average likes per tweet (last 30 days)
1.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
97.22%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
93.06%
Percentage of tweets with engagement (last 30 days)
94%
Percentage of tweets with engagement (last 30 days)
95.83%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
77.66%
Alexa Website Rank
Alexa Website Rank
306920
Alexa Website Rank
403027
Alexa Website Rank
274765
Alexa Website Rank
173418
Alexa Website Rank
112062
Alexa Website Rank
222327
Alexa Website Rank
332308
Alexa Website Rank
273274
Employee Rating
Employee Rating
3.9
Employee Rating
3.2
Employee Rating
4.0
Employee Rating
3.8
Employee Rating
3.3
Employee Rating
3.5
Employee Rating
N/A
Employee Rating
3.1

Financial

Revenue (est.)
Revenue (est.)
$7.9b (FY, 2019)
Revenue (est.)
CHF23.8m (FY, 2019)
Revenue (est.)
$15.3b (FY, 2018)
Revenue (est.)
$23.4b (FY, 2019)
Revenue (est.)
€37.1b (FY, 2015)
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$5b (FY, 2019)
Revenue (est.)
$2.5b (FY, 2019)
Cost of goods
Cost of goods
$782.2m (FY, 2019)
Cost of goods
N/A
Cost of goods
$587m (FY, 2018)
Cost of goods
$4.4b (FY, 2019)
Cost of goods
€10.9b (FY, 2015)
Cost of goods
$2b (FY, 2019)
Cost of goods
$394.5m (FY, 2019)
Cost of goods
$1.7b (FY, 2019)
Gross profit
Gross profit
$7.1b (FY, 2019)
Gross profit
N/A
Gross profit
$14.7b (FY, 2018)
Gross profit
$19b (FY, 2019)
Gross profit
€26.1b (FY, 2015)
Gross profit
$12.4b (FY, 2019)
Gross profit
$4.6b (FY, 2019)
Gross profit
$805.1m (FY, 2019)
Net income
Net income
$2.1b (FY, 2019)
Net income
(CHF494.6m) (FY, 2019)
Net income
$4b (FY, 2018)
Net income
$7.8b (FY, 2019)
Net income
€4.4b (FY, 2015)
Net income
$5.9b (FY, 2019)
Net income
$2.4b (FY, 2019)
Net income
$137.4m (FY, 2019)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
100 (FY, 2019)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
80 (FY, 2019)
Facilities
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
190 (FY, 2019)
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
39 (FY, 2019)
Patents (EU)
Patents (EU)
11 (FY, 2019)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
21 (FY, 2019)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (US)
Patents (US)
21 (FY, 2019)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
34 (FY, 2019)
Patents (US)
N/A
Patents (US)
21 (FY, 2019)
Patents (US)
N/A
Patents (US)
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
22 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
9 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
11 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
14 (Feb, 2020)
Phase III Trials Products
7 (Y, 2016)
Phase III Trials Products
6 (FY, 2019)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Products
Products
7 (FY, 2019)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
7 k (FY, 2019)
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
12 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
43 (Y, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A

Funding

Total funding raised
Total funding raised
$ 8.9m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Idorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.

View company
Celgene
HQ
Summit, US

Celgene Corporation is a biopharmaceutical company.

View company
Amgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company
Sanofi
HQ
Paris, FR
Employees
104,226↓ 2% decrease

Sanofi provides therapeutic solutions.

View company